Investigating coping strategies in patients with ischemic cardiovascular disease
CoPing strategIes-psyChological flexibiliTy in Patients Hospitalized for Ischemic cardiovascUlaR disEase (PICTURE)
This study looks at how patients with heart disease cope and adapt during their hospital stay to see if these strategies affect their health outcomes and willingness to join clinical trials.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 80 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Cardiocentro Ticino Academic / other |
| Locations | 1 site (Lugano) |
| Trial ID | NCT05696873 on ClinicalTrials.gov |
What this trial studies
This observational study aims to explore the coping strategies and psychological flexibility of patients hospitalized for ischemic cardiovascular disease. It will assess the relationship between these psychological factors and the recurrence of clinical events such as hospitalizations, myocardial infarctions, strokes, and deaths during follow-up. Additionally, the study will evaluate how these factors influence patients' decisions to participate in clinical trials and their adherence to cardiovascular medications.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are hospitalized for ischemic cardiovascular disease and can provide informed consent.
Not a fit: Patients with severe psychiatric disorders or cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of psychological factors that influence recovery and adherence in patients with ischemic cardiovascular disease.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown that psychological factors can significantly impact recovery and adherence in cardiovascular patients.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old * Able to provide informed consent * Able to speak and read in the local language spoken in hospital * Admission to the hospital for ischemic cardiovascular disease Exclusion Criteria: * Cannot provide written informed consent * Under judicial protection, tutorship or curatorship * Unable to understand and follow study-related instructions or unable to comply with study protocol * Cognitive impairment * Severe psychiatric disorders according to DSM-5-TR criteria diagnosed in the last 6 months
Where this trial is running
Lugano
- Enrico Frigoli — Lugano, Switzerland (Recruiting)
Study contacts
- Principal investigator: Marco Valgimigli, M.D., Ph.D — Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale, Lugano,
- Study coordinator: Marco Valgimigli, M.D., Ph.D
- Email: marco.valgimigli@eoc.ch
- Phone: +410918115111
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.